Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Newly Diagnosed Oligometastatic Prostate Cancer × apalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21 Neoplasm Metastasis 2 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostate Adenocarcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Castration Levels of Testosterone 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

apalutamide 1 abiraterone 1 Radiosurgery 1 Leuprolide 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

VA Office of Research and Development

Phase 2 Completed

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡